Molecular remission of Philadelphia/brc-abl-positive acute myeloid leukaemia after treatment with anti-CD 33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)

MP Vetten, JH (Joop) Jansen, BA Reijden, MS Berger, Mark Zijlmans, Bob Löwenberg

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)277-279
Number of pages3
JournalBritish Journal of Haematology
Volume111
DOIs
Publication statusPublished - 2000

Cite this